TrialMovement disorders : official journal of the Movement Disorder Society2017

First-in-human assessment of PRX002, an anti-α-synuclein monoclonal antibody, in healthy volunteers.

Dale B Schenk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.